Labs / Assays & in vitro testing

IRBM
Pomezia, Italy · irbm.com
AAALAC · GLP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
IRBM is a drug discovery research organization in Pomezia, near Rome, Italy. It supports programs from target validation through preclinical candidate selection across small molecules, peptides, antibodies, and cell therapy, serving pharmaceutical companies, biotech firms, foundations, and other research partners. Its work covers chemistry, biology, DMPK, in vivo pharmacology, structural biology, and specialized disease-area assays.
Their website has a general contact form; we send your quote request through it.
What they offer
Integrated drug discovery projects
Runs coordinated programs from target validation through preclinical candidate selection on a single site with one team.
Small molecule discovery
Advances small molecule programs from screening hits to preclinical candidates.
Medicinal chemistry
Designs, makes, tests, and analyzes compounds through iterative DMTA cycles to optimize chemical series.
Synthetic chemistry
Develops synthetic routes, parallel synthesis, scale-up, and purification to produce target compounds and libraries.
Computational chemistry
Uses structure-based and ligand-based in silico methods to support target analysis, hit identification, hit-to-lead, and lead optimization.
Peptide discovery
Develops peptide programs from starting sequence to candidate, including macrocyclic, complex, and protein peptides.
Antibody discovery
Identifies, characterizes, and validates monoclonal antibodies.
Display technologies
Provides peptide phage display, antibody phage display, and mRNA display for discovery workflows.
Assay development
Builds assays for target validation and screening workflows.
High throughput screening
Screens compound collections at scale to identify starting points for discovery programs.
High content screening
Applies image-based screening to support hit identification and biology-driven decision making.
Biophysical approaches
Uses biophysical methods to support characterization and discovery decisions.
Functional genomics
Supports target identification and validation with genomics-based studies.
Protein production
Produces proteins to support structural biology and assay work.
NMR
Uses NMR platforms for structural characterization and drug discovery support.
DMPK
Provides ADME, pharmacology, PK/PD, bioanalytics, and biotransformation studies.
In vivo pharmacology
Evaluates compounds in in vivo pharmacology studies.
Spatial biology
Offers spatial biology support within therapeutic area programs.
Bioinformatics
Provides bioinformatics support for therapeutic area programs and discovery workflows.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, mRNA, Cell therapy, Recombinant protein
- Species and models
- CAR-T, patient-derived models, Zika virus NS2B-NS3 protease
- Assays and studies
- assay development, high throughput screening, high content screening, biophysical approaches, functional genomics, HTT assays, blood brain barrier assay
- Instruments and platforms
- 400 MHz spectrometer, 500 MHz Bruker spectrometer, 600 MHz Bruker spectrometer, Biotage purification stations, HPLC, mass spectroscopy instruments, UPLC
- Scale and capacity
- compound collection of more than 400,000 high quality molecules, single research hub in Rome, Italy
- Therapeutic areas
- Oncology, Immuno-oncology, Spatial biology, Infectious disease, Neuroscience, Hepatitis B, Rare diseases, Viral disease, Cardiovascular disease, Metabolic disease, Neurodegenerative disorders, Ophthalmology, and 2 more
- Turnaround
- results become a decision within days
- What to send
- target hypothesis and the disease context behind it · a validated target and an assay ready to run at scale · compound collections · confirmed hit · sequence
- Type
- CRO
- Sites
- Pomezia (Rome), Italy · Rome, Italy
- Quality
- Code of Ethics · Policies and Certifications · Environmental, Health and Safety Policy · Energy Policy · Diversity and Inclusion Policy · Gender Equality Policy
- Serves
- Italy, Europe, worldwide
- Founded
- 2019
Similar labs. Venenum Biodesign, Aurigene Pharmaceutical Services, Evotec, EyeCRO
Found in a contract services directory. Listing built from irbm.com. Work here? Claim this listing.